中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
1期
86-87
,共2页
灯盏花素%醒脑静注射液%急性脑梗死%疗效
燈盞花素%醒腦靜註射液%急性腦梗死%療效
등잔화소%성뇌정주사액%급성뇌경사%료효
Breviscapine%Xingnaojing injection%Acute cerebral infarction%Curative effect
目的：观察灯盏花素联合醒脑静注射液治疗急性脑梗死的临床疗效。方法：89例急性脑梗死患者随机分为治疗组和对照组。对照组在常规治疗的基础上给予胞二磷胆碱0.5 g静滴，1次/d。治疗组在常规治疗的基础上给予灯盏花素50 mg静滴，2次/d，醒脑静注射液20 mL静滴，1次/d。比较两组临床疗效。结果：对照组总有效率75.00%，治疗组总有效率91.11%，两组比较，差异有统计学意义(P＜0.05)。两组均无明显不良反应。结论：灯盏花素联合醒脑静注射液治疗急性脑梗死安全有效，值得推广。
目的：觀察燈盞花素聯閤醒腦靜註射液治療急性腦梗死的臨床療效。方法：89例急性腦梗死患者隨機分為治療組和對照組。對照組在常規治療的基礎上給予胞二燐膽堿0.5 g靜滴，1次/d。治療組在常規治療的基礎上給予燈盞花素50 mg靜滴，2次/d，醒腦靜註射液20 mL靜滴，1次/d。比較兩組臨床療效。結果：對照組總有效率75.00%，治療組總有效率91.11%，兩組比較，差異有統計學意義(P＜0.05)。兩組均無明顯不良反應。結論：燈盞花素聯閤醒腦靜註射液治療急性腦梗死安全有效，值得推廣。
목적：관찰등잔화소연합성뇌정주사액치료급성뇌경사적림상료효。방법：89례급성뇌경사환자수궤분위치료조화대조조。대조조재상규치료적기출상급여포이린담감0.5 g정적，1차/d。치료조재상규치료적기출상급여등잔화소50 mg정적，2차/d，성뇌정주사액20 mL정적，1차/d。비교량조림상료효。결과：대조조총유효솔75.00%，치료조총유효솔91.11%，량조비교，차이유통계학의의(P＜0.05)。량조균무명현불량반응。결론：등잔화소연합성뇌정주사액치료급성뇌경사안전유효，치득추엄。
Objective:To observe the clinical curative effect of breviscapine combined with Xingnaojing injection in the treatment of acute cerebral infarction.Methods:89 cases of patients with acute cerebral infarction were randomly divided into the treatment group and the control group.The control group were given cytidine diphosphate choline 0.5 g by venoclysis on the basis of conventional treatment,1 times a day.On the basis of conventional treatment,the treatment group were given breviscapine 50 mg by venoclysis,2 times a day,and Xingnaojing injection 20 mL by venoclysis,1 time a day.The clinical curative effects of the two groups were compared.Results:The total effectiveness of the control group was 75.00% ,and that of the treatment group was 91.11%.The difference was statistically significant(P<0.05).There was no obvious adverse reaction of the two groups.Conclusion:Breviscapine combined with Xingnaojing injection in the treatment of acute cerebral infarction has good curative effect and is safe, which is worth promoting.
